| Literature DB >> 84951 |
Abstract
A randomised controlled trial of antipyrine (phenazone) in the prophylaxis of neonatal jaundice was completed in 48 women. Treatment of mothers from the 38th week of pregnancy reduced neonatal plasma-bilirubin concentrations on the 4th day after birth by an average of 44%. Prophylaxis of neonatal jaundice merits a wider trial.Entities:
Mesh：
Substances：
Year: 1979 PMID： 84951 DOI： 10.1016/s0140-6736(79)90709-8
Source DB: PubMed Journal: Lancet ISSN： 0140-6736 Impact factor: 79.321